An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance)
Federico Innocenti(AbbVie (United States)), Kouros Owzar(Duke University), Yoichi Furukawa(The University of Tokyo), Alexander B. Sibley(Duke University), Andrew B. Nixon(Duke University), Herbert I. Hurwitz(Duke Medical Center), Mark J. Ratain(University of Chicago), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Donna Niedzwiecki(Duke University), Daniel J. Crona(St. Jude Children's Research Hospital), Ace J. Hatch(Duke Medical Center), Hedy L. Kindler(University of Chicago), Chen Jiang, Dorothy Watson(University of North Carolina at Chapel Hill), Howard L. McLeod(Unknown), Stefanie Denning(University of North Carolina at Chapel Hill), Amy S. Etheridge(University of North Carolina at Chapel Hill)
Cited by 9
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k